The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Open accessAbstract
As part of a World Health Organization-led effort to update the empirical evidence base for the leishmaniases, national experts provided leishmaniasis case data for the last 5 years and information regarding treatment and control in their respective countries and a comprehensive literature review was conducted covering publications on leishmaniasis in 98 countries and three territories (see 'Leishmaniasis Country Profiles Text S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11, S12, S13, S14, S15, S16, S17, S18, S19, S20, S21, S22, S23, S24, S25, S26, S27, S28, S29, S30, S31, S32, S33, S34, S35, S36, S37, S38, S39, S40, S41, S42, S43, S44, S45, S46, S47, S48, S49, S50, S51, S52, S53, S54, S55, S56, S57, S58, S59, S60, S61, S62, S63, S64, S65, S66, S67, S68, S69, S70, S71, S72, S73, S74, S75, S76, S77, S78, S79, S80, S81, S82, S83, S84, S85, S86, S87, S88, S89, S90, S91, S92, S93, S94, S95, S96, S97, S98, S99, S100, S101'). Additional information was collated during meetings conducted at WHO regional level between 2007 and 2011. Two questionnaires regarding epidemiology and drug access were completed by experts and national program managers. Visceral and cutaneous leishmaniasis incidence ranges were estimated by country and epidemiological region based on reported incidence, underreporting rates if available, and the judgment of national and international experts. Based on these estimates, approximately 0.2 to 0.4 cases and 0.7 to 1.2 million VL and CL cases, respectively, occur each year. More than 90% of global VL cases occur in six countries: India, Bangladesh, Sudan, South Sudan, Ethiopia and Brazil. Cutaneous leishmaniasis is more widely distributed, with about one-third of cases occurring in each of three epidemiological regions, the Americas, the Mediterranean basin, and western Asia from the Middle East to Central Asia. The ten countries with the highest estimated case counts, Afghanistan, Algeria, Colombia, Brazil, Iran, Syria, Ethiopia, North Sudan, Costa Rica and Peru, together account for 70 to 75% of global estimated CL incidence. Mortality data were extremely sparse and generally represent hospital-based deaths only. Using an overall case-fatality rate of 10%, we reach a tentative estimate of 20,000 to 40,000 leishmaniasis deaths per year. Although the information is very poor in a number of countries, this is the first in-depth exercise to better estimate the real impact of leishmaniasis. These data should help to define control strategies and reinforce leishmaniasis advocacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mucocutaneous and visceral disease can be lethal if untreated, but most deaths are attributable to visceral leishmaniasis (103).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Depending on the species, Leishmania can cause self-healing cutaneous lesions (e.g., L. tropica, L. major, L. mexicana, and L. pifanoi), disfiguring mucocutaneous disease (e.g., L. braziliensis and L. guyanensis), or severe visceral illness (e.g., L. donovani and L. Infantum chagasi).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [103]
Experimental — accuracy not yet measuredIn the citing paper
“we must consider the important zoonotic potential of the diseases studied, as the presence of human infections or risk of infection has already been described (5, 24, 25, 28).”
From Current Distribution of Selected Vector-Borne Diseases in Dogs in Spain (2020) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1996) · Cited by 6,884
Disease control priorities in developing countries
(2006) · Choice Reviews Online · doi:10.5860/choice.44-0343 · Cited by 3,636
Leishmaniasis: current situation and new perspectives
Desjeux, P. M. P. (2004) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2004.03.004 · Cited by 2,329 · cited 1×
“Reported leishmaniasis case figures are widely acknowledged to represent gross underestimates of the true burden, but studies that measure the degree of underreporting are rare [23].”
BackgroundBank, W. (1993) · doi:10.1596/0-1952-0890-0 · Cited by 2,213
King, C. H., Dickman, K. R., & Tisch, D. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66457-4 · Cited by 898 · cited 1×
“The accuracy of this measure depends on the reliability of the incidence, duration, severity and mortality data for a given condition, as well as the underlying assumptions used in the calculations [7,14].”
BackgroundHealth metrics and evaluation: strengthening the science
Murray, C. J., & Frenk, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60526-7 · Cited by 849
Hotez, P. J., Molyneux, D. H., Fenwick, A., Ottesen, E. A., Sachs, S. E., & Sachs, J. D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030102 · Cited by 822 · cited 1×
“Although estimated to cause the ninth largest disease burden among individual infectious diseases, leishmaniasis is largely ignored in discussions of tropical disease priorities [1,2].”
BackgroundAlvar, J., Yactayo, S., & Bern, C. (2006) · Trends in Parasitology · doi:10.1016/j.pt.2006.09.004 · Cited by 813 · cited 1×
“This consignment to critical oblivion results from its complex epidemiology and ecology, the lack of simple, easily-applied tools for case management and the paucity of current incidence data, and often results in a failure on the part of policy-makers to recognize its importance [3,4].”
BackgroundDesjeux, P. M. P. (1996) · Clinics in Dermatology · doi:10.1016/0738-081x(96)00057-0 · Cited by 588 · cited 1×
“Visceral leishmaniasis (VL) results in death if not treated, the majority of leishmaniasis deaths go unrecognized, and even with treatment access, VL may result in case-fatality rates of 10–20% [17,18,19,20,21,22].”
BackgroundLibrary, W. (2010) · Cited by 584
The leishmaniases as emerging and reemerging zoonoses
Ashford, R. W. (2000) · International Journal for Parasitology · doi:10.1016/s0020-7519(00)00136-3 · Cited by 583 · cited 1×
“In order to facilitate expert judgment regarding the probable accuracy of the figures presented here, we defined geographical regions consistent with the major ecological foci of leishmaniasis transmission, rather than official WHO regions [31,32,33].”
BackgroundMeasuring the Burden of Neglected Tropical Diseases: The Global Burden of Disease Framework
Mathers, C. D., Ezzati, M., & López, A. D. (2007) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000114 · Cited by 527 · cited 2×
“The evidence base for the neglected tropical diseases (NTDs) is acknowledged to be particularly problematic [9,16].”
BackgroundTurner, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92377-5 · Cited by 388
The Leishmaniases in biology and medicine
Peters, W., & Killick‐Kendrick, R. (1987) · Cited by 387
Complexities of Assessing the Disease Burden Attributable to Leishmaniasis
Bern, C., Maguire, J. H., & Alvar, J. (2008) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000313 · Cited by 370 · cited 4×
“[4,52] We hope the data presented here will allow a more nuanced interpretation of published disease burden estimates, and the uncertainties in these data will spur activities to improve the evidence base for leishmaniasis and other neglected diseases.”
BackgroundInfluentialEstimation of population at risk of infection and number of cases of Leishmaniasis
Ashford, R. W., Desjeux, P. M. P., & deRaadt, P. (1992) · Parasitology Today · doi:10.1016/0169-4758(92)90249-2 · Cited by 358 · cited 1×
“[48,49] We are acutely cognizant of the uncertainties inherent in the data, and for that reason, have presented rough ranges rather than single estimates for each outcome.”
Background(2010) · PubMed · Cited by 346
Pawlisz, M. (2011) · Array · Cited by 317
Fichoux, Y. L., Quaranta, J.-F., Aufeuvre, J.-P., Lelièvre, A., Marty, P., Suffia, I., Rousseau, D., & Kubar, J. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1953-1957.1999 · Cited by 314
Socioeconomic aspects of neglected tropical diseases
Conteh, L., Engels, T., & Molyneux, D. H. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61422-7 · Cited by 272 · cited 1×
“The evidence base for the neglected tropical diseases (NTDs) is acknowledged to be particularly problematic [9,16].”
BackgroundZijlstra, E. E., El-Hassan, A. M., Ismael, A., & Ghalib, H. W. (1994) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1994.51.826 · Cited by 232 · cited 2×
“[22,46] A recent study from South Sudan estimated that 91% of all kalaazar deaths went unrecognized.”
BackgroundSeaman, J., MERCER, A. J., & Sondorp, E. (1996) · International Journal of Epidemiology · doi:10.1093/ije/25.4.862 · Cited by 218 · cited 1×
“[22,46] A recent study from South Sudan estimated that 91% of all kalaazar deaths went unrecognized.”
BackgroundHotez, P. J., Remme, J. H. F., Buss, P. M., Alleyne, G. A. O., Morel, C. M., & Breman, J. G. (2004) · Clinical Infectious Diseases · doi:10.1086/382077 · Cited by 214 · cited 1×
“Although estimated to cause the ninth largest disease burden among individual infectious diseases, leishmaniasis is largely ignored in discussions of tropical disease priorities [1,2].”
BackgroundRisk Factors for Kala-Azar in Bangladesh
Bern, C., Hightower, A. W., Chowdhury, R., Ali, M., Amann, J., Wagatsuma, Y., Haque, R., Kurkjian, K. M., Vaz, L. E., Begum, M., et al. (2005) · Emerging infectious diseases · doi:10.3201/eid1105.040718 · Cited by 213 · cited 1×
“Visceral leishmaniasis (VL) results in death if not treated, the majority of leishmaniasis deaths go unrecognized, and even with treatment access, VL may result in case-fatality rates of 10–20% [17,18,19,20,21,22].”
BackgroundCollin, S. M., Davidson, R. N., Ritmeijer, K., Keus, K., Melaku, Y., Kipngetich, S., & Davies, C. R. (2004) · Clinical Infectious Diseases · doi:10.1086/381203 · Cited by 180 · cited 1×
“Visceral leishmaniasis (VL) results in death if not treated, the majority of leishmaniasis deaths go unrecognized, and even with treatment access, VL may result in case-fatality rates of 10–20% [17,18,19,20,21,22].”
BackgroundThe world's most neglected diseases
Yamey, G. (2002) · BMJ · doi:10.1136/bmj.325.7357.176 · Cited by 179
Anthroponotic Cutaneous Leishmaniasis, Kabul, Afghanistan
Reithinger, R., Mohsen, M., Aadil, K., Sidiqi, M., Erasmus, P., & Coleman, P. G. (2003) · Emerging infectious diseases · doi:10.3201/eid0906.030026 · Cited by 152 · cited 2×
“Underreporting considered moderate (5–10-fold) based on estimates of incidence from population-based surveys [30].”
King, C. H., & Bertino, A.-M. (2008) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000209 · Cited by 150 · cited 1×
“years (DALYs) lost, a measurement first promoted in the 1993 World Development Report and the focus of intense scrutiny ever since [11,12,13].”
BackgroundSerious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India
Singh, S. P., Reddy, D. C. S., Rai, M., & Sundar, S. (2006) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2006.01647.x · Cited by 136
Cutaneous leishmaniasis in red kangaroos: isolation and characterisation of the causative organisms
Rose, K. A., Curtis, J., Baldwin, T. M., Mathis, A., Kumar, B., Sakthianandeswaren, A., Spurck, T. P., Choy, J. L., & Handman, E. (2004) · International Journal for Parasitology · doi:10.1016/j.ijpara.2004.03.001 · Cited by 126 · cited 1×
“[41] Human infections due to lower trypanosomatids are also excluded.”
BackgroundCardiomyopathy in adult Holstein Friesian cattle.
Borsberry, S., & Colloff, A. (1999) · PubMed · Cited by 108
VISCERAL LEISHMANIASIS: CONSEQUENCES OF A NEGLECTED DISEASE IN A BANGLADESHI COMMUNITY
Ahluwalia, I. B., Bern, C., Costa, C. M. A., Akter, T., Chowdhury, R., Ali, M., ALAM, D., Kenah, E., Amann, J., Islam, M., et al. (2003) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2003.69.624 · Cited by 100 · cited 1×
“[43,44,45] In South Sudan, one community-based longitudinal study demonstrated a case-fatality rate of 20% in a settled village in peacetime; in areas of conflict, famine or population displacement mortality rates are much higher.”
BackgroundEcology and epidemiology: new world
Shaw, J. J., & Lainson, R. (1987) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 98
Ecology and epidemiology: Old World.
Ashford, R. W., Bettini, S., Peters, W., & Killick‐Kendrick, R. (1987) · Cited by 87
AbouZahr, C., & Vaughan, J. P. (2000) · PubMed · doi:10.1590/s0042-96862000000500010 · Cited by 82 · cited 1×
“years (DALYs) lost, a measurement first promoted in the 1993 World Development Report and the focus of intense scrutiny ever since [11,12,13].”
BackgroundLower trypanosomatids in HIV/AIDS patients
Chicharro, C., & Alvar, J. (2003) · Annals of Tropical Medicine and Parasitology · doi:10.1179/000349803225002552 · Cited by 78 · cited 1×
“[42].”
VIRGIN SOIL: THE SPREAD OF VISCERAL LEISHMANIASIS INTO UTTAR PRADESH, INDIA
BARNETT, P. G., Singh, S. P., Bern, C., Hightower, A. W., & Sundar, S. (2005) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2005.73.720 · Cited by 78 · cited 1×
“[43,44,45] In South Sudan, one community-based longitudinal study demonstrated a case-fatality rate of 20% in a settled village in peacetime; in areas of conflict, famine or population displacement mortality rates are much higher.”
BackgroundEstimation of Under-Reporting of Visceral Leishmaniasis Cases in Bihar, India
Singh, V. P., Ranjan, A., Topno, R. K., Verma, R. B., Siddique, N. A., Ravidas, V. N., Kumar, N., Pandey, K., & Das, P. K. (2010) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2010.09-0235 · Cited by 76 · cited 13×
“[24,26,29] Based on these publications, countrylevel VL underreporting magnitude was categorized as follows: mild (1.2- to 1.8-fold based on data from Brazil [25]); severe (4.0- to 8.0-fold based on data from India [27,28]); and an intermediate category of moderate (2.0 to 4.0-fold) underreporting.”
BackgroundMethodInfluentialNarain, J. P., Dash, A. P., Parnell, B., Bhattacharya, S., Barua, S., Bhatia, R., & Savioli, L. (2010) · Bulletin of the World Health Organization · doi:10.2471/blt.09.072322 · Cited by 66 · cited 1×
“[4,51] Many key measures of progress, such as validation of trends seen in surveillance data and accurate case-fatality rates, can only be obtained through the active collection of community-based data.”
BackgroundCattand, P., Desjeux, P. M. P., Guzmán, M., Jannin, J. G., Kroeger, A., Medici, A., Musgrove, P., Nathan, M. B., Shaw, A. P. M., & Schofield, C. (2006) · Cited by 64
American visceral leishmaniasis (kala-azar) in hospitalized children from an endemic area
Rey, L. C., Martins, C. V., Ribeiro, H. B., & Lima, A. Â. M. (2005) · Jornal de Pediatria · doi:10.2223/jped.1286 · Cited by 55 · cited 1×
“Visceral leishmaniasis (VL) results in death if not treated, the majority of leishmaniasis deaths go unrecognized, and even with treatment access, VL may result in case-fatality rates of 10–20% [17,18,19,20,21,22].”
BackgroundAnálise dos registros de leishmaniose visceral pelo método de captura-recaptura
Maia‐Elkhoury, A. N. S., Carmo, E. H., de Sousa-Gomes, M. L., & Mota, E. (2007) · Revista de Saúde Pública · doi:10.1590/s0034-89102007000600007 · Cited by 53
Unseen Kala‐azar deaths in south Sudan (1999–2002)
Collin, S. M., Coleman, P. G., Ritmeijer, K., & Davidson, R. N. (2006) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2006.01589.x · Cited by 46
Comparison of Active and Passive Case Detection of Cutaneous Leishmaniasis in Guatemala
Copeland, H. W., Arana, B. A., & Navin, T. R. (1990) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1990.43.257 · Cited by 46 · cited 3×
“[24,26,29] Based on these publications, countrylevel VL underreporting magnitude was categorized as follows: mild (1.”
BackgroundMosleh, I. M., Geith, E., Natsheh, L., Abdel-Dayem, M., & Abotteen, N. (2008) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2008.02063.x · Cited by 41 · cited 3×
“[24,26,29] Based on these publications, countrylevel VL underreporting magnitude was categorized as follows: mild (1.”
BackgroundAssessment of Leishmaniasis notification system in Santiago del Estero, Argentina, 1990-1993.
n, Z. E. Y., QUIGLEY, M. A., Davies, C. R., Rodrigues, L. C., & Segura, E. L. (2001) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.65.27 · Cited by 37 · cited 7×
“One additional article was identified from author literature collections, yielding 3 articles with empirical data regarding VL and 3 for CL underreporting [24,25,26,27,28,29].”
BackgroundInfluentialHistory of Kala-Azar in India.
Gupta, P. C. S. (1947) · PubMed · Cited by 34
Hirve, S. S., Singh, S. P., Kumar, N., Banjara, M. R., Das, P., Sundar, S., Rijal, S., Joshi, A. B., Kroeger, A., Varghese, B., et al. (2010) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2010.09-0685 · Cited by 33 · cited 1×
“[4,52] We hope the data presented here will allow a more nuanced interpretation of published disease burden estimates, and the uncertainties in these data will spur activities to improve the evidence base for leishmaniasis and other neglected diseases.”
BackgroundKala-azar epidemic in Varanasi district, India
Kumar, R., Kumar, P., Chowdhary, R., Pai, K., Mishra, C., Kumar, K., Pandey, H. P., Singh, V., & Sundar, S. (2000) · The Indian Journal of Pediatrics · doi:10.1007/bf02859467 · Cited by 25 · cited 1×
“[43,44,45] In South Sudan, one community-based longitudinal study demonstrated a case-fatality rate of 20% in a settled village in peacetime; in areas of conflict, famine or population displacement mortality rates are much higher.”
BackgroundNeronov, V. M., Strelkova, M. V., Shurkhal, A. A., Luschekina, A. A., & Mm, A. (1987) · PubMed · Cited by 9
(2006) · World Bank, Washington, DC eBooks · doi:10.1596/978-0-8213-6179-5/chpt-23 · Cited by 3 · cited 1×
“Estimates of disease burden are widely used by policy-makers and funding organizations to establish priorities [7,8,9,10].”
Background
Flagged first, then by citations
Research works printed but not linked: 1
- AN Maia-Elkhoury, 2007, [Analysis of visceral leishmaniasis reports by the capture-recapture method]., Rev Saude Publica, 41, 931
Cited by
Sorted by citations
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
Arango Duque, G., & Descoteaux, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00491 · Cited by 2,708
“Mucocutaneous and visceral disease can be lethal if untreated, but most deaths are attributable to visceral leishmaniasis (103).”
BackgroundBurza, S., Croft, S. L., & Boelaert, M. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31204-2 · Cited by 1,928
Akhoundi, M., Kuhls, K., Cannet, A., Votýpka, J., Marty, P., Delaunay, P., & Séréno, D. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004349 · Cited by 1,017
Cutaneous leishmaniasis: Immune responses in protection and pathogenesis
Scott, P., & Novais, F. O. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.72 · Cited by 591
Steverding, D. (2017) · Parasites & Vectors · doi:10.1186/s13071-017-2028-5 · Cited by 502
Metadata
- Authors
- Alvar, J., Vélez, I. D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., Boer, M. D., & the WHO Leishmaniasis Control Team
- Affiliations
- World Health Organization (CH)
- Universidad de Antioquia (CO)
- Centers for Disease Control and Prevention (US)
- Instituto de Salud Carlos III (ES)
- Corresponding author
- Alvar, Jorge
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-05-31
- Volume
- 7
- Issue
- 5
- Pages
- e35671
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3365071
- OpenAlex
- W2107915297
- Cited by
- 5,141
- References
- 51
- Citations by year
- 2026: 177 · 2025: 229 · 2024: 257 · 2023: 305 · 2022: 358 · 2021: 456 · 2020: 468 · 2019: 458 · 2018: 515 · 2017: 440 · 2016: 465 · 2015: 361 · 2014: 404 · 2013: 200 · 2012: 38
- FWCI
- 310.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Sanofi
- Universidad de Medellín
- Pan American Health Organization
- Agencia Española de Cooperación Internacional para el Desarrollo
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Research on Leishmaniasis Studies
- Health Sciences › Medicine › Infectious Diseases › Leprosy Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › Brucella: diagnosis, epidemiology, treatment
- Keywords
- leishmaniasis, visceral leishmaniasis, cutaneous leishmaniasis, leishmaniasis incidence, country profile, leishmaniasis control, leishmaniasis treatment, access to medicines, neglected tropical diseases, case data
- MeSH terms
- Female, Geography, Humans, Leishmaniasis, Male, Time Factors, World Health Organization, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
